Glucose Lowering to Control Macrovascular Disease in Type 2 Diabetes Treating the Wrong Surrogate End Point?

被引：14
|
作者：
Goodarzi, Mark O. [5 ,6 ]
Psaty, Bruce M. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA
[2] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA
[3] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA
[4] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
[5] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Inst Med Genet, Los Angeles, CA 90048 USA
[6] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2008年 / 300卷 / 17期
关键词：
D O I：
10.1001/jama.2008.510
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2051 / 2053
页数：3
相关论文
共 50 条
  • [1] Intensive glucose control and macrovascular outcomes in type 2 diabetes
    F. M. Turnbull
    C. Abraira
    R. J. Anderson
    R. P. Byington
    J. P. Chalmers
    W. C. Duckworth
    G. W. Evans
    H. C. Gerstein
    R. R. Holman
    T. E. Moritz
    B. C. Neal
    T. Ninomiya
    A. A. Patel
    S. K. Paul
    F. Travert
    M. Woodward
    Diabetologia, 2009, 52 : 2288 - 2298
  • [2] Intensive glucose control and macrovascular outcomes in type 2 diabetes
    Diabetologia, 2009, 52 : 2470 - 2470
  • [3] Intensive glucose control and macrovascular outcomes in type 2 diabetes
    Turnbull, F. M.
    Abraira, C.
    Anderson, R. J.
    Byington, R. P.
    Chalmers, J. P.
    Duckworth, W. C.
    Evans, G. W.
    Gerstein, H. C.
    Holman, R. R.
    Moritz, T. E.
    Neal, B. C.
    Ninomiya, T.
    Patel, A. A.
    Paul, S. K.
    Travert, F.
    Woodward, M.
    DIABETOLOGIA, 2009, 52 (11) : 2288 - 2298
  • [4] Cardiovascular disease and intensive glucose lowering in type 2 diabetes
    Younis, N.
    Soran, H.
    Hassanein, M.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2009, 102 (04) : 293 - 296
  • [5] Does blood glucose control prevent macrovascular complications of type 2 diabetes?
    Charbonnel, Bernard
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (5-6): : 897 - 906
  • [6] Preventing macrovascular complications in type 2 diabetes mellitus: Glucose control and beyond
    Stancoven, Amy
    McGuire, Darren K.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (11A): : 5H - 11H
  • [7] Does blood glucose control prevent macrovascular complications of type 2 diabetes? DISCUSSION
    Villet, Richard
    Bouchard, Philippe
    Godeau, Pierre
    Bringer, Jacques
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (5-6): : 906 - 908
  • [8] Intensive glucose lowering in type 2 diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2008, 50 (1289): : 49 - 49
  • [9] Proteinuria, macrovascular disease and blood pressure control in patients with type 2 diabetes
    Evans, AJ
    Krentz, AJ
    DIABETES, 2000, 49 : A370 - A370
  • [10] Glycaemic control and macrovascular complications of type 2 diabetes
    Dandona, Paresh
    Chaudhuri, Ajay
    NATIONAL MEDICAL JOURNAL OF INDIA, 2008, 21 (06): : 271 - 274
12345